Skip to main content

Israel Molina Romero

Sóc metge i responsable de la Unitat de Medicina Tropical i Salut Internacional

Institutions of which they are part

Head of group
Infectious Diseases
Vall Hebron Institut de Recerca
Infectious Diseases
General Hospital

Israel Molina Romero

Institutions of which they are part

Head of group
Infectious Diseases
Vall Hebron Institut de Recerca
Infectious Diseases
General Hospital

Sóc metge i responsable de la Unitat de Medicina Tropical i Salut Internacional

Llicenciat en Medicina per la UAB. Adjunt del Servei de Malalties Infeccioses Hospital Universitari Vall d'Hebron. Responsable de la Unitat de Medicina Tropical i Salut Internacional de l'Hospital Vall d'Hebron. Director del Programa de Salut Internacional de l'ICS. Experiència clínica i de recerca a Guinea Ecuatorial, Brasil i Angola.

Projects

Point-of-Care electroquímico para la detección rápida y cuantitativa de malaria

IP: Eva Baldrich Rubio
Collaborators: Francesc Zarzuela Serrat, Israel Molina Romero, Adrián Sánchez Montalvá, Elena Sulleiro Igual, Ines Mercedes Oliveira Souto
Funding agency: Instituto de Salud Carlos III
Funding: 80410
Reference: DTS17/00145
Duration: 01/01/2018 - 31/12/2020

Incorporació Dr. Israel Molina a la RETICS en Malalties tropicals

IP: Israel Molina Romero
Collaborators: Maria Luisa Aznar Ruiz de Alegria, Antoni Soriano Arandes, Diana Pou Ciruelo, Begoña Treviño Maruri, Juan Espinosa Pereiro, Pau Bosch Nicolau, Nuria Serre Delcor, Fernando M Salvador Velez, Jordi Gómez i Prat, Adrián Sánchez Montalvá, Elena Sulleiro Igual, Ines Mercedes Oliveira Souto
Funding agency: Instituto de Salud Carlos III
Funding: 130542.5
Reference: RD16/0027/0003
Duration: 01/01/2017 - 30/06/2022

PICAT (Plataforma Integral per al Control d¿ Arbovirosis a CaTalunya)

IP: Israel Molina Romero
Collaborators: Diana Pou Ciruelo, Fernando M Salvador Velez, Esperanza Esteban Serna, Raisa Morales Martinez, Adrián Sánchez Montalvá, Elena Sulleiro Igual
Funding agency: Generalitat de Catalunya - Departament de Salut
Funding: 125216.28
Reference: SLT002/16/00466
Duration: 01/01/2017 - 31/12/2019

Sol·licitud d'intensificació per a la dedicació en el projecte "BEnznidazol and triazol REsearch group for Nanomedicine and Innovation on Chagas diseasE (BERENICE)" de la European Comission.

IP: Sol·licitud d'intensificació per a la dedicació en el projecte "BEnznidazol and triazol REsearch group for Nanomedicine and Inno
Collaborators: Israel Molina Romero, Laia Perez Lasarte
Funding agency: Instituto de Salud Carlos III
Funding: 18000
Reference: INT16/00252
Duration: 09/01/2017 - 31/12/2017

Related news

The study aims to investigate how excess body fat alters the number and function of T lymphocytes, leading to a greater predisposition to infectious diseases.

This project will make societies aware of their rights related to sexual and reproductive health and empower young people to make informed and appropriate choices.

On World Clinical Trials Day, we highlight some of the studies we have participated in that confirm the efficacy of new drugs, allowing their approval by regulatory agencies.

Related professionals

Maria Lopez Mendoza

Maria Lopez Mendoza

Predoctoral researcher
Head and Neck Cancer: Biomedical Research Cancer Stem cells
Read more
Anna Deàs Just

Anna Deàs Just

Predoctoral researcher
Diabetes and Metabolism
Read more
Carlos Ernesto Marrero Eligio de la Puente

Carlos Ernesto Marrero Eligio de la Puente

Administration and Management
Neurovascular Diseases
Read more
Sara Escalera Anzola

Sara Escalera Anzola

Predoctoral researcher
Diabetes and Metabolism
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.